Division of Gastroenterology, Hepatology, and Endoscopy, Brigham and Women’s Hospital, Harvard Medical SchoolBoston, MA
4 - Efficacy and Safety of Subcutaneous Guselkumab Induction and Maintenance Therapy in Participants With Ulcerative Colitis: Results Through Week 48 From the Phase 3 ASTRO Study
Monday, October 27, 20258:36 AM - 8:48 AM PDT
69 - Clinical and Endoscopic Improvements With Risankizumab Treatment in Patients With Moderate-to-Severe Crohn’s Disease Who Previously Failed Ustekinumab
Wednesday, October 29, 20259:10 AM - 9:20 AM PDT